Literature DB >> 17971133

ECG clues for diagnosing ventricular tachycardia mechanism.

Michael P Riley1, Francis E Marchlinski.   

Abstract

Three mechanisms underlie the initiation and maintenance of ventricular tachycardia: automaticity, triggered activity, and reentry. As straightforward as these mechanisms are, assessing which mechanism is operative in a particular patient's ventricular tachycardia can be difficult. The optimal treatment strategy for ventricular tachycardia in a given patient can be influenced by the mechanism underlying the ventricular tachycardia. Appropriately counseling patients, choosing the optimal pharmacologic agent that maximizes efficacy while minimizing undesirable side effects, risks, and toxicities, as well as recommending and timing ablative therapy all hinge on identifying the probable mechanism of ventricular tachycardia. Much has been published regarding invasive electrophysiologic maneuvers that allow for correct diagnosis of ventricular tachycardia mechanism. The aim of this clinical review is to provide insight into VT mechanisms based on ECG clues of spontaneous arrhythmia events and the response to pharmacologic manipulation prior to invasive electrophysiologic evaluation.

Entities:  

Mesh:

Year:  2007        PMID: 17971133     DOI: 10.1111/j.1540-8167.2007.01007.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  3 in total

1.  HRS policy statement: clinical cardiac electrophysiology fellowship curriculum: update 2011.

Authors:  Mark S Link; Derek V Exner; Mark Anderson; Michael Ackerman; Amin Al-Ahmad; Bradley P Knight; Steven M Markowitz; Elizabeth S Kaufman; David Haines; Samuel J Asirvatham; David J Callans; J Paul Mounsey; Frank Bogun; Sanjiv M Narayan; Andrew D Krahn; Suneet Mittal; Jagmeet Singh; John D Fisher; Sumeet S Chugh
Journal:  Heart Rhythm       Date:  2011-06-14       Impact factor: 6.343

2.  The persistent sodium current blocker riluzole is antiarrhythmic and anti-ischaemic in a pig model of acute myocardial infarction.

Authors:  Steven M Weiss; David A Saint
Journal:  PLoS One       Date:  2010-11-24       Impact factor: 3.240

3.  RR interval variability in the evaluation of ventricular tachycardia and effects of implantable cardioverter defibrillator therapy.

Authors:  Keita Tsukahara; Yasushi Oginosawa; Yoshihisa Fujino; Toshihiro Honda; Kan Kikuchi; Masatsugu Nozoe; Takayuki Uchida; Hitoshi Minamiguchi; Koichiro Sonoda; Masahiro Ogawa; Takeshi Ideguchi; Yoshihisa Kizaki; Toshihiro Nakamura; Kageyuki Oba; Satoshi Higa; Keiki Yoshida; Keishiro Yagyu; Taro Miyamoto; Yasunobu Yamagishi; Hisaharu Ohe; Ritsuko Kohno; Masaharu Kataoka; Yutaka Otsuji; Haruhiko Abe
Journal:  J Arrhythm       Date:  2021-05-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.